UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052843
Receipt number R000054355
Scientific Title Validation of a Recently Developed Fluoroscopic Video Analysis Workstation (Radwis) for Reliable Diagnosis of Acute Pulmonary Thromboembolism
Date of disclosure of the study information 2023/11/20
Last modified on 2023/11/19 20:01:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An Exploratory Study on the Diagnosis of Pulmonary Thromboembolism (PTE) Using Radwisp and Determination of Treatment Efficacy

Acronym

Validation of a Recently Developed Fluoroscopic Video Analysis Workstation (Radwis) for Reliable Diagnosis of Acute Pulmonary Thromboembolism

Scientific Title

Validation of a Recently Developed Fluoroscopic Video Analysis Workstation (Radwis) for Reliable Diagnosis of Acute Pulmonary Thromboembolism

Scientific Title:Acronym

Validation of a Recently Developed Fluoroscopic Video Analysis Workstation (Radwis) for Reliable Diagnosis of Acute Pulmonary Thromboembolism

Region

Japan


Condition

Condition

acute pulmonary thromboembolism

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To validate Radwisp as a diagnostic tool for APE and evaluate its potential for patients who present with symptoms of suspected APE.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Accuracy of Radwisp-based Diagnosis of APE or Absence of APE

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

24 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

10 residents and 10 cardiologists in our hospital.

Key exclusion criteria

none

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Fukamachi

Organization

Nihon University School of Medicine

Division name

Caridiology

Zip code

173-8610

Address

30-1 Ohyaguchi, Kamicho, Itabashi-Ku, Tokyo 173-8610, Japan

TEL

0339728111

Email

fukamachi.daisuke@nihon-u.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Fukamachi

Organization

Nihon University School of Medicine

Division name

Caridiology

Zip code

173-8610

Address

30-1 Ohyaguchi, Kamicho, Itabashi-Ku, Tokyo 173-8610, Japan

TEL

0339728111

Homepage URL


Email

fukamachi.daisuke@nihon-u.ac.jp


Sponsor or person

Institute

Nihon university itabashi hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

tokyo


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nihon university itabashi hospital

Address

30-1 Ohyaguchi, Kamicho, Itabashi-Ku, Tokyo 173-8610, Japan

Tel

0339728111

Email

komoda.nozomi@nihon-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 20 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 12 Month 24 Day

Date of IRB

2022 Year 02 Month 09 Day

Anticipated trial start date

2022 Year 02 Month 09 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2023 Year 11 Month 19 Day

Last modified on

2023 Year 11 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054355